The Association of Hormonal Intake and Demographic Factors With Breast Cancer Risk. An Egyptian Case-controlled Study
1 other identifier
observational
200
0 countries
N/A
Brief Summary
The aim of the current study is to investigate the association between hormonal intake, occupational and demographic factors, and the risk of breast cancer (BC) among Egyptian females.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Nov 2021
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 16, 2021
CompletedStudy Start
First participant enrolled
November 16, 2021
CompletedFirst Posted
Study publicly available on registry
November 26, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 31, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
March 31, 2022
CompletedNovember 26, 2021
November 1, 2021
3 months
November 16, 2021
November 16, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Confirmed Breast Cancer Patients
Patients who were diagnosed with histopathologically confirmed breast cancer and were during the past 2 years to 2021 (2019-2020).
During the past 2 years to 2021 (2019-2020).
Study Arms (2)
Cases
1.Cases (100) are those eligible patients who were diagnosed with histopathologically confirmed breast cancer and were during the past 2 years to 2021 (2019-2020).
Matched Controls
2\. Matched controls (100) are those participants presenting to the screening clinic and were not diagnosed with breast cancer during the past 2 years to 2021 (2019-2020). Candidates are to be of same range of age (+/-3 years); and similar visiting period (+/-2 months). All controls were confirmed as having no diagnosis of breast cancer, with negative findings on physical breast examination, and breast sono-mammographic screening.
Interventions
History of hormonal use as follows: 1. Reason for hormonal use: contraception, fertility promotion, Polycystic ovary syndrome (PCOS) 2. Duration of hormonal use 3. Type of hormonal drug used: dose, hormone type, route of administration
Eligibility Criteria
Eligible candidates will be stratified as cases or matched controls as follows: 1. Cases (100) are those eligible patients who were diagnosed with histopathologically confirmed breast cancer and were during the past 2 years to 2021 (2019-2020). 2. Matched controls (100) are those participants presenting to the screening clinic and were not diagnosed with breast cancer during the past 2 years to 2021 (2019-2020). Candidates are to be of same range of age (+/-3 years); and similar visiting period (+/-2 months). All controls were confirmed as having no diagnosis of breast cancer, with negative findings on physical breast examination, and breast sono-mammographic screening.
You may qualify if:
- Age \> 18 and \< 70
You may not qualify if:
- Diagnosed with other concurrent malignancies.
- A prior history of another cancer.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- NewGiza Universitylead
- Ain Shams Universitycollaborator
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Lecturer in Clinical Pharmacy Practice Department
Study Record Dates
First Submitted
November 16, 2021
First Posted
November 26, 2021
Study Start
November 16, 2021
Primary Completion
January 31, 2022
Study Completion
March 31, 2022
Last Updated
November 26, 2021
Record last verified: 2021-11